首页> 外文期刊>Nature >Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2
【24h】

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

机译:丙型肝炎病毒包膜糖蛋白2核心胞外域的结构

获取原文
获取原文并翻译 | 示例
       

摘要

Hepatitis C virus (HCY) is a significant public health concern with approximately 160 million people infected worldwide. HCV infection often results in chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. No vaccine is available and current therapies are effective against some, but not all, genotypes. HCV is an enveloped virus with two surface glycoproteins (E1 and E2). E2 binds to the host cell through interactions with scavenger receptor class B type Ⅰ (SR-BI) and CD81, and serves as a target for neutralizing antibodies. Little is known about the molecular mechanism that mediates cell entry and membrane fusion, although E2 is predicted to be a class Ⅱ viral fusion protein. Here we describe the structure of the E2 core domain in complex with an antigen-binding fragment (Fab) at 2.4 A resolution. The E2 core has a compact, globular domain structure, consisting mostly of β-strands and random coil with two small α-helices. The strands are arranged in two, perpendicular sheets (A and B), which are held together by an extensive hydrophobic core and disulph-ide bonds. Sheet A has an IgG-like fold that is commonly found in viral and cellular proteins, whereas sheet B represents a novel fold. Solution-based studies demonstrate that the full-length E2 ectodo-main has a similar globular architecture and does not undergo significant conformational or oligomeric rearrangements on exposure to low pH. Thus, the IgG-like fold is the only feature that E2 shares with class Ⅱ membrane fusion proteins. These results provide unprecedented insights into HCV entry and will assist in developing an HCV vaccine and new inhibitors.%目前还没有针对丙肝病毒的疫苗,所以重要的是要对该病毒的感染过程有更多了解。Joseph Marcotrigiano及同事获得了丙肝病毒表面糖蛋白E2的核心域的晶体结构。该结构显示,与人们的预料相反的是,E2不大可能是病毒融合蛋白。这项研究有助于澄清E2所起作用以及丙肝病毒的进入机制。
机译:丙型肝炎病毒(HCY)是一个重大的公共卫生问题,全球约有1.6亿人被感染。 HCV感染通常会导致慢性肝炎,肝硬化和肝细胞癌。没有可用的疫苗,当前的疗法对某些而非全部基因型有效。 HCV是一种带有两种表面糖蛋白(E1和E2)的包膜病毒。 E2通过与Ⅰ型清道夫受体(SR-BI)和CD81的相互作用与宿主细胞结合,并成为中和抗体的靶标。尽管E2被认为是Ⅱ类病毒融合蛋白,但对介导细胞进入和膜融合的分子机制知之甚少。在这里,我们描述了E2核心域与抗原结合片段(Fab)以2.4 A分辨率复合的结构。 E2磁芯具有紧凑的球形域结构,主要由β链和带有两个小α螺旋的无规线圈组成。股线排列成两个垂直的板(A和B),它们通过广泛的疏水核和二硫键保持在一起。片A具有在病毒和细胞蛋白中常见的IgG样折叠,而片B代表新的折叠。基于溶液的研究表明,全长E2异主链具有相似的球形结构,并且在暴露于低pH值时不会发生明显的构象或寡聚重排。因此,IgG样折叠是E2与Ⅱ类膜融合蛋白共有的唯一特征。这些结果为HCV进入提供了空前的见识,并将有助于开发HCV疫苗和新抑制剂。%目前还没有针对丙肝病毒的疫苗,所以重要的是要该病毒的感染过程有更多了解。JosephMarcotrigiano及同事该结构显示,与人们的预料相反的是,E2不大可能是病毒融合蛋白。由此研究证明E2所造成以及丙肝病毒的进入机制。

著录项

  • 来源
    《Nature》 |2014年第7500期|381-384a2|共5页
  • 作者单位

    Center for Advanced Biotechnology and Medicine, Department of Chemistry and Chemical Biology, Rutgers University, 679 Hoes Lane West, Piscataway, New Jersey 08854, USA;

    Center for Advanced Biotechnology and Medicine, Department of Chemistry and Chemical Biology, Rutgers University, 679 Hoes Lane West, Piscataway, New Jersey 08854, USA;

    Center for Advanced Biotechnology and Medicine, Department of Chemistry and Chemical Biology, Rutgers University, 679 Hoes Lane West, Piscataway, New Jersey 08854, USA;

    Division of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, 100 Woodruff Circle, Atlanta, Georgia 30322, USA;

    Center for Advanced Biotechnology and Medicine, Department of Chemistry and Chemical Biology, Rutgers University, 679 Hoes Lane West, Piscataway, New Jersey 08854, USA;

    Center for Advanced Biotechnology and Medicine, Department of Chemistry and Chemical Biology, Rutgers University, 679 Hoes Lane West, Piscataway, New Jersey 08854, USA;

    Division of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, 100 Woodruff Circle, Atlanta, Georgia 30322, USA;

    Center for Advanced Biotechnology and Medicine, Department of Chemistry and Chemical Biology, Rutgers University, 679 Hoes Lane West, Piscataway, New Jersey 08854, USA;

    Division of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, 100 Woodruff Circle, Atlanta, Georgia 30322, USA;

    Division of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, 100 Woodruff Circle, Atlanta, Georgia 30322, USA;

    Division of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, 100 Woodruff Circle, Atlanta, Georgia 30322, USA,Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, 100 Woodruff Circle, Atlanta, Georgia 30322, USA;

    Center for Advanced Biotechnology and Medicine, Department of Chemistry and Chemical Biology, Rutgers University, 679 Hoes Lane West, Piscataway, New Jersey 08854, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:53:02

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号